UniProt ID | CHSTF_HUMAN | |
---|---|---|
UniProt AC | Q7LFX5 | |
Protein Name | Carbohydrate sulfotransferase 15 | |
Gene Name | CHST15 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 561 | |
Subcellular Localization |
Golgi apparatus membrane Single-pass type II membrane protein . A small fraction may also be present at the cell surface, where it acts as a B-cell receptor. |
|
Protein Description | Sulfotransferase that transfers sulfate from 3'-phosphoadenosine 5'-phosphosulfate (PAPS) to the C-6 hydroxyl group of the GalNAc 4-sulfate residue of chondroitin sulfate A and forms chondroitin sulfate E containing GlcA-GalNAc(4,6-SO(4)) repeating units. It also transfers sulfate to a unique non-reducing terminal sequence, GalNAc(4SO4)-GlcA(2SO4)-GalNAc(6SO4), to yield a highly sulfated structure similar to the structure found in thrombomodulin chondroitin sulfate. May also act as a B-cell receptor involved in BCR ligation-mediated early activation that mediate regulatory signals key to B-cell development and/or regulation of B-cell-specific RAG expression; however such results are unclear in vivo.. | |
Protein Sequence | MRHCINCCIQLLPDGAHKQQVNCQGGPHHGHQACPTCKGENKILFRVDSKQMNLLAVLEVRTEGNENWGGFLRFKKGKRCSLVFGLIIMTLVMASYILSGAHQELLISSPFHYGGFPSNPSLMDSENPSDTKEHHHQSSVNNISYMKDYPSIKLIINSITTRIEFTTRQLPDLEDLKKQELHMFSVIPNKFLPNSKSPCWYEEFSGQNTTDPYLTNSYVLYSKRFRSTFDALRKAFWGHLAHAHGKHFRLRCLPHFYIIGQPKCGTTDLYDRLRLHPEVKFSAIKEPHWWTRKRFGIVRLRDGLRDRYPVEDYLDLFDLAAHQIHQGLQASSAKEQSKMNTIIIGEASASTMWDNNAWTFFYDNSTDGEPPFLTQDFIHAFQPNARLIVMLRDPVERLYSDYLYFASSNKSADDFHEKVTEALQLFENCMLDYSLRACVYNNTLNNAMPVRLQVGLYAVYLLDWLSVFDKQQFLILRLEDHASNVKYTMHKVFQFLNLGPLSEKQEALMTKSPASNARRPEDRNLGPMWPITQKILRDFYRPFNARLAQVLADEAFAWKTT | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
49 | Phosphorylation | KILFRVDSKQMNLLA EEEEEECCCCCEEEE | 23.17 | 29514088 | |
118 | O-linked_Glycosylation | FHYGGFPSNPSLMDS CCCCCCCCCHHHCCC | 60.14 | OGP | |
160 | Phosphorylation | KLIINSITTRIEFTT EEHHHHHHHCCEEEC | 15.16 | - | |
161 | Phosphorylation | LIINSITTRIEFTTR EHHHHHHHCCEEECC | 28.16 | - | |
201 | Phosphorylation | NSKSPCWYEEFSGQN CCCCCCCCCCCCCCC | 16.58 | - | |
213 | Phosphorylation | GQNTTDPYLTNSYVL CCCCCCCCCCCEEEE | 29.03 | - | |
217 | Phosphorylation | TDPYLTNSYVLYSKR CCCCCCCEEEEEEHH | 16.04 | 17081983 | |
218 | Phosphorylation | DPYLTNSYVLYSKRF CCCCCCEEEEEEHHH | 9.13 | 22817900 | |
221 | Phosphorylation | LTNSYVLYSKRFRST CCCEEEEEEHHHHHH | 11.34 | 17081983 | |
222 | Phosphorylation | TNSYVLYSKRFRSTF CCEEEEEEHHHHHHH | 17.13 | 17081983 | |
364 | N-linked_Glycosylation | AWTFFYDNSTDGEPP CEEEEECCCCCCCCC | 35.12 | UniProtKB CARBOHYD | |
434 | Phosphorylation | ENCMLDYSLRACVYN HHHHHCHHHHHHHHC | 15.85 | 24719451 | |
443 | Phosphorylation | RACVYNNTLNNAMPV HHHHHCCCCCCCCCC | 27.50 | 24719451 | |
504 | Ubiquitination | NLGPLSEKQEALMTK CCCCCCHHHHHHHCC | 50.49 | 21906983 | |
504 (in isoform 1) | Ubiquitination | - | 50.49 | 21906983 | |
510 | Phosphorylation | EKQEALMTKSPASNA HHHHHHHCCCCCCCC | 29.26 | 22210691 | |
511 | Ubiquitination | KQEALMTKSPASNAR HHHHHHCCCCCCCCC | 40.24 | 2190698 | |
511 (in isoform 1) | Ubiquitination | - | 40.24 | 21906983 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of CHSTF_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of CHSTF_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of CHSTF_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
HCK_HUMAN | HCK | physical | 10749872 | |
CALX_HUMAN | CANX | physical | 26496610 | |
CCNB1_HUMAN | CCNB1 | physical | 26496610 | |
IF5A1_HUMAN | EIF5A | physical | 26496610 | |
ZEP1_HUMAN | HIVEP1 | physical | 26496610 | |
LGAT1_HUMAN | LPGAT1 | physical | 26496610 | |
CEPT1_HUMAN | CEPT1 | physical | 26496610 | |
SYFM_HUMAN | FARS2 | physical | 26496610 | |
CASC3_HUMAN | CASC3 | physical | 26496610 | |
RB6I2_HUMAN | ERC1 | physical | 26496610 | |
KLDC2_HUMAN | KLHDC2 | physical | 26496610 | |
S43A3_HUMAN | SLC43A3 | physical | 26496610 | |
RABL6_HUMAN | RABL6 | physical | 26496610 | |
PKHG1_HUMAN | PLEKHG1 | physical | 26496610 | |
TPC_HUMAN | SLC25A19 | physical | 26496610 | |
S35E1_HUMAN | SLC35E1 | physical | 26496610 | |
ILKAP_HUMAN | ILKAP | physical | 26496610 | |
PHF5A_HUMAN | PHF5A | physical | 26496610 | |
NDUF2_HUMAN | NDUFAF2 | physical | 26496610 | |
TJAP1_HUMAN | TJAP1 | physical | 26496610 | |
CALX_HUMAN | CANX | physical | 28514442 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...